Lawrence Nadya 4

Accession 0001192482-12-000136

CIK 0000352998other

View on SEC.gov Company Profile

Filed

May 29, 8:00 PM ET

Accepted

May 30, 9:54 AM ET

Size

47.2 KB

Accession

0001192482-12-000136

Insider Transaction Report

Form 4

Period: 2012-05-11

IGI LABORATORIES, INCIG

Lawrence Nadya

Exec. VP-Sales and Marketing

Transactions

Exercise/Conversion
Common Stock
2012-05-23$0.65/sh+7,000$4,550→ 22,928 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-05-11−15→ 196,485 total
Exercise: $0.65Exp: 2012-05-23→ Common Stock (15 underlying)
Exercise/Conversion
Common Stock
2012-05-16$0.65/sh+608$395→ 16,536 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-05-18−843→ 193,249 total
Exercise: $0.65Exp: 2012-05-23→ Common Stock (843 underlying)
Sale
Common Stock
2012-05-15$1.00/sh−1,485$1,485→ 15,928 total
Sale
Common Stock
2012-05-21$1.00/sh−907$907→ 15,928 total
Exercise/Conversion
Common Stock
2012-05-17$0.65/sh+300$195→ 16,228 total
Exercise/Conversion
Stocl Option (Right to Buy)
2012-05-17−300→ 194,092 total
Exercise: $0.65Exp: 2012-05-23→ Common Stock (300 underlying)
Sale
Common Stock
2012-05-11$1.05/sh−15$16→ 15,928 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-05-22−10,000→ 182,342 total
Exercise: $0.65Exp: 2012-05-23→ Common Stock (10,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2012-05-16−608→ 194,392 total
Exercise: $0.65Exp: 2012-05-23→ Common Stock (608 underlying)
Exercise/Conversion
Common Stock
2012-05-15$0.65/sh+1,485$965→ 17,413 total
Sale
Common Stock
2012-05-18$1.00/sh−843$843→ 15,928 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-05-21−5,342→ 170,000 total
Exercise: $0.65Exp: 2012-05-23→ Common Stock (5,342 underlying)
Sale
Common Stock
2012-05-22$0.95/sh−10,000$9,500→ 15,928 total
Exercise/Conversion
Common Stock
2012-05-11$0.65/sh+15$10→ 15,943 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-05-21−907→ 192,342 total
Exercise: $0.65Exp: 2012-05-23→ Common Stock (907 underlying)
Exercise/Conversion
Common Stock
2012-05-21$0.65/sh+907$590→ 16,835 total
Exercise/Conversion
Common Stock
2012-05-22$0.65/sh+10,000$6,500→ 25,928 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-05-15−1,485→ 195,000 total
Exercise: $0.65Exp: 2012-05-23→ Common Stock (1,485 underlying)
Exercise/Conversion
Common Stock
2012-05-18$0.65/sh+843$548→ 16,771 total
Exercise/Conversion
Common Stock
2012-05-23$0.65/sh+5,342$3,472→ 21,270 total
Exercise/Conversion
Stock Option (Right to Buy)
2012-05-23−7,000→ 175,342 total
Exercise: $0.65Exp: 2012-05-23→ Common Stock (7,000 underlying)
Sale
Common Stock
2012-05-16$1.00/sh−608$608→ 15,928 total
Sale
Common Stock
2012-05-17$1.02/sh−300$306→ 15,928 total
Sale
Common Stock
2012-05-23$0.95/sh−7,000$6,650→ 15,928 total

Footnotes (1)

[F1]The options vested immediately upon the date of grant, May 23, 2002.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

IGI LABORATORIES, INC

CIK 0000352998

→

Entity typeother

Related Parties

filerCIK 0001358088

Filing Metadata

Form type: 4
Filed: May 29, 8:00 PM ET
Accepted: May 30, 9:54 AM ET
Size: 47.2 KB

View on SEC.gov